Sign in

CIK 0001613780 · Non-accelerated filer<br>Smaller reporting company

DBV Technologies S.A.

Sign in to watch
Ticker
DBVTF
Exchange
Nasdaq, OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
France
Entity type
operating
Phone
330155427878
Business address
107 AVENUE DE LA REPUBLIQUE, CHATILLON, France

Securities

  • DBVT American Depositary Shares Nasdaq
  • DBVTF Common stock OTC
  1. 4 Grant or award Chief Financial Officer acquired 19,000 shares (grant or award)
  2. 4 Open-market sale Chief Medical Officer sold 1,785 shares at $0.98 ($1,749)
  3. 4 Open-market sale Chief Medical Officer sold 1,042 shares at an average $1.37 ($1,425)
  4. 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 17,094 shares at $0.83 ($14,188)
  5. 4 Open-market buy Director bought 1,825 shares at $0.89 ($1,624)
  6. 4 Open-market sale Chief Medical Officer sold 2,245 shares at $1.74 ($3,906)
  7. 4 Grant or award Chief Financial Officer acquired 19,000 shares (grant or award)
  8. 4 Derivatives Options or other derivatives
  9. 4 Grant or award Chief Medical Officer acquired 35,000 shares (grant or award)
  10. 3 Insider Initial Statement of Ownership
  11. 4 Open-market buy Director bought 12,000 shares at $1.52 ($18,240)
  12. 4 Derivatives Options or other derivatives
  13. 4 Open-market sale Chief Medical Officer sold 2,261 shares at an average $3.02 ($6,821)
  14. 4 Grant or award Chief Financial Officer acquired 8,000 shares (grant or award)
  15. 4 Open-market buy Director bought 15,000 shares at $1.62 ($24,300)
  16. 3 Insider Initial Statement of Ownership
  17. 4 Grant or award Director acquired 11,875,000 shares (grant or award)
  18. 4 Derivatives Options or other derivatives
  19. 4 Grant or award Chief Medical Officer acquired 8,700 shares (grant or award)
  20. 4 Grant or award Chief Financial Officer acquired 5,000 shares (grant or award)

Page 2 of 4 · 61 filings